Zymoflam Forte Tablet is a combination pharmaceutical formulation containing Bromelain (180 mg), Trypsin (96 mg), and Rutoside (200 mg), designed to provide potent anti-inflammatory, proteolytic, and vasoprotective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins and reduces inflammation and edema by modulating inflammatory mediators. Trypsin, another proteolytic enzyme, complements this action by promoting the degradation of inflammatory exudates and enhancing tissue repair processes. Rutoside, a bioflavonoid with antioxidant properties, strengthens capillary walls, reduces capillary permeability, and improves microcirculation, thereby aiding in the management of vascular disorders and edema. The synergistic effect of these active ingredients makes Zymoflam Forte effective in the treatment of acute and chronic inflammatory conditions, including musculoskeletal injuries, postoperative swelling, and venous insufficiency. It is also utilized as an adjunct therapy in managing trauma, burns, and certain dermatological conditions characterized by inflammation and edema. Zymoflam Forte should be used under medical supervision, considering contraindications such as hypersensitivity to any component, bleeding disorders, or concurrent anticoagulant therapy. Dosage and duration of treatment should be individualized based on clinical response and patient tolerance.